65 related articles for article (PubMed ID: 21187156)
21. Decreased FOXP3 expression in small airways of smokers with COPD.
Isajevs S; Taivans I; Strazda G; Kopeika U; Bukovskis M; Gordjusina V; Kratovska A
Eur Respir J; 2009 Jan; 33(1):61-7. PubMed ID: 18684844
[TBL] [Abstract][Full Text] [Related]
22. Maternal and personal cigarette smoking synergize to increase airflow limitation in adults.
Upton MN; Smith GD; McConnachie A; Hart CL; Watt GC
Am J Respir Crit Care Med; 2004 Feb; 169(4):479-87. PubMed ID: 14630616
[TBL] [Abstract][Full Text] [Related]
23. [Some aspects of pulmonary vascular remodelling in smokers and patients with mild COPD].
Firă-Mladinescu O; Vasile L; Suciu C; Fira-Mlădinescu C; Noveanu L; Răducan A; Săvoiu G; Muntean D; Mihalaş G; Tudorache V
Pneumologia; 2008; 57(1):7-16. PubMed ID: 18543655
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of human calcium-activated chloride channel 1 is correlated with mucus overproduction in the airways of Chinese patients with chronic obstructive pulmonary disease.
Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
Chin Med J (Engl); 2007 Jun; 120(12):1051-7. PubMed ID: 17637221
[TBL] [Abstract][Full Text] [Related]
25. Relation between duration of smoking cessation and bronchial inflammation in COPD.
Lapperre TS; Postma DS; Gosman MM; Snoeck-Stroband JB; ten Hacken NH; Hiemstra PS; Timens W; Sterk PJ; Mauad T
Thorax; 2006 Feb; 61(2):115-21. PubMed ID: 16055612
[TBL] [Abstract][Full Text] [Related]
26. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
[TBL] [Abstract][Full Text] [Related]
27. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients.
Caramori G; Casolari P; Di Gregorio C; Saetta M; Baraldo S; Boschetto P; Ito K; Fabbri LM; Barnes PJ; Adcock IM; Cavallesco G; Chung KF; Papi A
Histopathology; 2009 Sep; 55(3):321-31. PubMed ID: 19723147
[TBL] [Abstract][Full Text] [Related]
28. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
[TBL] [Abstract][Full Text] [Related]
29. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
30. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
31. Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction.
Calabrese C; Bocchino V; Vatrella A; Marzo C; Guarino C; Mascitti S; Tranfa CM; Cazzola M; Micheli P; Caputi M; Marsico SA
Respir Med; 2006 Aug; 100(8):1415-22. PubMed ID: 16497496
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
33. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
34. Severity of airflow limitation is associated with severity of airway inflammation in smokers.
Di Stefano A; Capelli A; Lusuardi M; Balbo P; Vecchio C; Maestrelli P; Mapp CE; Fabbri LM; Donner CF; Saetta M
Am J Respir Crit Care Med; 1998 Oct; 158(4):1277-85. PubMed ID: 9769292
[TBL] [Abstract][Full Text] [Related]
35. Carotid Artery Stiffness is Associated With Cognitive Performance in Former Smokers With and Without Chronic Obstructive Pulmonary Disease.
Hoth KF; Moreau KL; Weinberger HD; Holm KE; Meschede K; Crapo JD; Make BJ; Moser DJ; Kozora E; Bowler RP; Pierce GL; Ten Eyck P; Wamboldt FS
J Am Heart Assoc; 2020 May; 9(9):e014862. PubMed ID: 32338117
[TBL] [Abstract][Full Text] [Related]
36. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
[TBL] [Abstract][Full Text] [Related]
37. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
39. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
[TBL] [Abstract][Full Text] [Related]
40. Reduced apoptosis of CD8+ T-lymphocytes in the airways of smokers with mild/moderate COPD.
Siena L; Gjomarkaj M; Elliot J; Pace E; Bruno A; Baraldo S; Saetta M; Bonsignore MR; James A
Respir Med; 2011 Oct; 105(10):1491-500. PubMed ID: 21612902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
